Biotech Firms Drive IPO Rebound While 'Unicorns' Gear Up
The initial public offering market ended midyear on a roll and appears poised for a strong second half of 2020, powered by a robust biotechnology sector and potential debuts from venture-backed...To view the full article, register now.
Already a subscriber? Click here to view full article